Palliative care integration and end-of-life outcomes in veterans with metastatic colon cancer. This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This abstract does not include a ...
Results show that the first-line antidiabetic drug metformin and the second-line sodium glucose co-transporter-2 (SGLT-2) inhibitors lower the risk of dementia and AD. Sulfonylureas significantly ...
Final results of phase Ib/II study of durvalumab and guadecitabine in advanced clear cell renal cell carcinoma (ccRCC) and biomarker analysis. This is an ASCO Meeting Abstract from the 2023 ASCO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results